Susquehanna International Group’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-50,978
Closed -$160K 5606
2020
Q3
$160K Buy
50,978
+14,632
+40% +$45.9K ﹤0.01% 3969
2020
Q2
$106K Sell
36,346
-13,375
-27% -$39K ﹤0.01% 3903
2020
Q1
$140K Buy
49,721
+39,657
+394% +$112K ﹤0.01% 3949
2019
Q4
$33K Sell
10,064
-90,202
-90% -$296K ﹤0.01% 3822
2019
Q3
$217K Sell
100,266
-27,353
-21% -$59.2K ﹤0.01% 3774
2019
Q2
$400K Buy
+127,619
New +$400K ﹤0.01% 3164
2019
Q1
Sell
-72,679
Closed -$211K 5349
2018
Q4
$211K Buy
+72,679
New +$211K ﹤0.01% 2883
2018
Q3
Sell
-116,523
Closed -$273K 5474
2018
Q2
$273K Buy
+116,523
New +$273K ﹤0.01% 2806
2018
Q1
Sell
-118,047
Closed -$324K 5262
2017
Q4
$324K Buy
118,047
+41,047
+53% +$113K ﹤0.01% 2774
2017
Q3
$261K Hold
77,000
﹤0.01% 2579
2017
Q2
$190K Buy
77,000
+63,400
+466% +$156K ﹤0.01% 3098
2017
Q1
$31K Sell
13,600
-267,105
-95% -$609K ﹤0.01% 3091
2016
Q4
$595K Buy
+280,705
New +$595K ﹤0.01% 2795
2016
Q3
Hold
0
4693
2016
Q2
Sell
-47,941
Closed -$160K 4809
2016
Q1
$160K Sell
47,941
-58,593
-55% -$196K ﹤0.01% 3441
2015
Q4
$377K Buy
106,534
+72,241
+211% +$256K ﹤0.01% 3223
2015
Q3
$172K Sell
34,293
-102,220
-75% -$513K ﹤0.01% 3831
2015
Q2
$878K Buy
136,513
+17,691
+15% +$114K ﹤0.01% 2838
2015
Q1
$836K Buy
118,822
+67,421
+131% +$474K ﹤0.01% 2619
2014
Q4
$396K Buy
51,401
+19,499
+61% +$150K ﹤0.01% 3527
2014
Q3
$238K Sell
31,902
-62,799
-66% -$469K ﹤0.01% 3411
2014
Q2
$916K Buy
94,701
+6,654
+8% +$64.4K ﹤0.01% 2523
2014
Q1
$732K Sell
88,047
-724,479
-89% -$6.02M ﹤0.01% 2331
2013
Q4
$6.86M Buy
812,526
+790,149
+3,531% +$6.67M ﹤0.01% 837
2013
Q3
$178K Buy
+22,377
New +$178K ﹤0.01% 3199
2013
Q2
Hold
0
3943